Loading

Wall Street Journal

  • by Allen St. Pierre, NORML Executive Director October 8, 2010

    The longtime government supporters of Cannabis Prohibition are very nervous about the upcoming binding ballot initiative in California which appears on track to be approved by millions of state voters. There is much evidence for this assertion:

    A few weeks ago the Los Angeles Times published a so-called unprecedented ‘jointly’ signed letter by all of the former drug czars (aka, Directors of the Office of Drug Control Policy) crowing against cannabis and the voter initiative in California that is likely going to pass this November 2nd. Ironically, or not, when readers go to the Los Angeles Times’ webpage to read the former czars rant-n-rave, they’re pitched cannabis-related Google ads.

    It is hard to imagine Cannabis Prohibition surviving too much longer when pro-cannabis ads ring government propaganda!

    This week the Wall Street Journal regrettably compromised its usual rhetorical commitment to ‘less government’, more ‘free markets’ and ‘personal responsibility’ by publishing an absurdly argued op-ed from every previous administrator from the Drug Enforcement Administration (DEA) calling on the Obama administration to actively oppose the democratic will of the voters in America’s most important state politically and economically if they choose, as it appears likely they will based on recent polling, to legalize cannabis for responsible adult use, sales and taxation.

    Why the ‘we don’t like big government’ and free market-oriented editorial page editors of the Wall Street Journal decided to  shill for a federal government agency, who, according to a report from the Office of Management and Budget is little more than a bureaucratic sacred cow, has one of the worse performance records in the history of otherwise bloated inside-the-beltway bureaucracies that the Journal editors usually relish skewing is beyond me.

    Firstly, the rant from these former ‘head narcs’ against the Democratic Obama administration comes mainly from partisan Republicans.

    Second, as has been noted in NORML’s submitted letter-to-the-editor at the Wall Street Journal (which we understand will be published on Monday, October 11) and at Reason, these former DEA heads make a flaccid and intellectually dishonest assertion that a state must be saddled with a failed federal public policy like Cannabis Prohibition in contradiction to the popular will of it’s voters. Really? Is this true? Then why do states like California, Colorado, New Mexico, District of Columbia, New Jersey, Rhode Island and Maine have systems in place to authorize the retail sale of medical cannabis and to tax the product as well?

    Is the sole focus on ‘legalization’ by these former anti-drug technocrats a left-handed acknowledgement that medical cannabis use and sales are in fact lawful and taxed commerce at the state level now, while at the same time trying advance the unpersuasive argument that states sanctioning and taxing non-medical cannabis is now going over some kind of impermissible line of state autonomy? Or worse, a violation of international treaties?

    One can understand on the level of myth-making, propagandizing, brain-washing, indoctrinating, embracing pseudo science and possessing the most tin ears politically why these men (and a woman) who’ve represented the ‘big lie’ to the American public and Congress for so long are reticent to  1) acknowledge that they were at all wrong in opposing cannabis legalization (even notably medical access and industrial hemp), 2) that they’re logically afraid of rightly being branded as ‘liars’ and 3) having to cop to the hundreds of billions of tax dollars that have been both wasted and left uncollected for decades…to say nothing of the 21 million arrests and millions of incarcerations since 1937.

    One can almost feel bad for these individuals for a nanosecond when considering how badly pop culture is currently treating them, and how I personally believe history will likely cast dark shadows over their championing of Cannabis Prohibition.

    What do I mean by ‘casting dark shadows’?

    Here’s two prime examples from the list of former DEA heads:

    After making a reputation at the DEA for opposing NORML’s administrative law victory in challenging the DEA’s mis-scheduling of cannabis in Schedule I, Jack Lawn went on to fame and fortune as the CEO of the Century Council–the main non-profit organization funded by the hard booze lobby to promote ‘alcohol awareness and to deter youth access and drunk driving’.

    Peter Bensinger, who has a business partnership with former drug czar Robert DuPont providing anti-drug advice to fortune 500 companies and drug testing services (including to members of Congress), also has a daughter who used to be a spokesmodel for Miller Beer.

    Yep…you can’t make this stuff up!

    These lame and too-late-to-the-game monologues by all of these former government agency heads who made careers (and small fortunes) lying about cannabis and demonizing cannabis consumers and patients in the Los Angeles Times (shame on you!) and the Wall Street Journal (doubly shame on you!) are likely going to be as successful as the last and great ‘unprecedented’ attempt by Cannabis Prohibition’s A-Team to thwart the direct will of the citizens regarding setting a new path to end prohibition, when, every living US president (Ford, Carter, Reagan, Bush 1.0 and Clinton) signed a 1996 op-ed for the Los Angeles Times (so much shame for this paper’s historical support for Cannabis Prohibition!) against a then supposedly radical and society-threatening Prop. 215–which the voters approved in California at a higher rate than they did for returning President Clinton back to office.

    As has been predicted recently by a number of polling firms and political scientists in California, the state’s voters may well endorse in greater numbers for legalizing cannabis in three weeks then they will in supporting any major political candidates for elective office. One would think that these mainstream, duopoly political candidates would finally say ‘Uncle!’ and end their stubborn and unfounded opposition to a long-sought end to cannabis prohibition in California if only out of the pure embarrassment of how wrong they’ve been in bucking public sentiment and the free market.

    Something tells me I probably shouldn’t hold my breath.

  • by Allen St. Pierre, NORML Executive Director March 27, 2010

    Someone should clue in neo-con John Walters (who Drug Policy Alliance director Ethan Nadelmann aptly described once as Bill Bennett’s ‘Mini-Me’) that he no longer is compelled by statute to lie about cannabis any more seeking to thwart the will of American citizens. Blessedly, taxpayers are no longer paying him high wages to lie to beat the band. But, apparently the ‘Weakly Standard’ and Hudson Institute are willing to pay up for Walter’s anti-pot prevarications.

    Walters—a political operative who revolves in and out of government jobs when Republicans control the executive branch—in a gratuitously written essay attempts to both praise the Democratic president while condemning him at the exact same time. A difficult feat to achieve, and Walters only disappoints with petty partisanship and self-promotion.

    Obama Just Says No to Soros

    From the March 22, 2010 Weekly Standard

    by John Walters

    For anyone who feared that the Obama administration would abandon efforts to control illegal drugs, the president’s first year in office has been on balance reassuring.

    The anti-antidrug camp had high hopes that Barack Obama would end “drug prohibition.” Last year, George Soros, a leading proponent of drug legalization and perhaps the most generous financial backer of the president, seemed in a position to get the change he wanted. In fact, Obama drug czar Gil Kerlikowske made it his first order of business to tell the press he was ending “the drug war.” More significantly, Attorney General Eric Holder announced that federal enforcement regarding “medical marijuana” would be dialed back, which caused the number of storefront marijuana shops in Los Angeles to skyrocket.

    Things are looking a little different a year later, however. Kerlikowske turned old school and proclaimed that drug legalization was not in the administration’s “vocabulary.” The Drug Enforcement Administration (DEA) continues to enforce marijuana laws in California (although without vocal support from Holder). And the Obama administration just released its first drug control budget requesting a fully funded, well, drug war. At the end of the Bush administration, federal drug control spending in fiscal year 2009 was $15 billion—65 percent of it devoted to border security, law enforcement, and other supply control efforts. Obama wants $15.5 billion in 2011, 64 percent for supply control—an increase of $100 million over Bush’s final year.

    President Obama did not speak of the importance of drug treatment in his first State of the Union address as his predecessor had, but he requested a bit more money for it—all to the good. And he even tried to avoid adding these funds to the most unaccountable federal treatment programs.

    Last year, Congress and the administration cut prevention funding 17 percent, the only significant change from 2009. This year, the administration is seeking to restore some, but not all, of that cut.

    The drug-legalization zealots may be singing “Meet the new boss, same as the old boss.” But with the exception of the Carter administration, when some senior members of the White House staff favored legalization, every president from Richard Nixon through Barack Obama—Republican and Democrat—has sought to attack both supply and demand. It was during the Carter administration that the drug problem exploded, leading to the worst destruction from substance abuse in living memory and the enduring root of the smaller problem still with us today.

    It is very important that President Obama has not listened to George Soros on drugs. Should we expect anything more? Are there any signs that the president cares about the drug problem? Will he actually show some leadership on this issue? If he wanted to, he could teach young people something. He could say that illegal drugs make people sick, and his generation did not understand this and paid a horrible price for its ignorance. Now we know better, and we should act like it. If he wanted to show real courage, he could say we know that marijuana makes people sick and that marijuana is the illegal drug causing the greatest dependency and addiction by far. He could even say it is time to stop several decades of lying to ourselves about marijuana and teaching that lie to our children.

    President Obama as no other president before him could use his appeal to youth to end, almost overnight, the cultural dogma that drugs are cool. It would be easy for him to become the greatest contributor to drug abuse prevention since Nancy Reagan—and he could explain how difficult it is to stop using these substances even when you know better, as he has found with cigarettes.

    Of course, none of this is likely to happen. The Obama administration has shown itself willing to spend to support antidrug programs, but it probably will not lead at home and abroad in the areas where truly historic gains are possible.

    President Alvaro Uribe in Colombia has all but taken his country back from drug trafficking terrorists. One result of Uribe’s victories is that dramatically less cocaine reaches American cities. Is that not important to President Obama? The Obama administration could draw attention to this magnificent example of turning the tide against drugs and terror and explain how it happened—a great drug war victory led by Colombia’s president and supported by both the Clinton and the Bush administrations. If similar efforts are led, adapted, and sustained in Mexico and Afghanistan, the damage caused by cocaine, heroin, and marijuana in the United States and globally can be dramatically reduced. The changes would be profound. Does President Obama see this? Thus far, there is no evidence he thinks about it at all.

    The president surely did not need Charles Lane of the Washington Post to tell him “medical marijuana is an insult to our intelligence.” But the president and all his key officials—Eric Holder, Secretary of Health and Human Services Kathleen Sebelius, Commissioner of the Food and Drug Administration Margaret Hamburg, and even Gil Kerlikowske—are playing dumb as “medical marijuana” is brought to Washington, D.C. The agencies of the federal government know what a dangerous fraud this has been in California and particularly in its large cities—Los Angeles, Oakland, and San Francisco. It is beyond question that “medical marijuana” fosters rapid rises in abuse, addiction, and crime. The Post has reported this in detail. Does the capital of the United States need a bigger drug problem? Are all these Obama administration officials really too busy to make the obvious argument that “medical marijuana” is a stupid and dangerous fraud?

    We are fortunate that President Obama has resisted the wrongheaded advice of George Soros. But it is not enough. Today, leadership is needed on curbing use of marijuana, helping Mexico defeat the traffickers, and working to integrate the battle against terror and drugs in Afghanistan. On these issues the new boss is failing, and there are already troubling survey results indicating youth drug use may be about to rise. Attitudes about drugs are a product of teaching, not mere spending. The annual reports of historic rates of substance abuse among aging Baby Boomers should have taught us by now that exposing our children to these substances is not dangerous for them only as teens. All too often, substance abuse lasts a lifetime.

    Truth and history vs. Walters’ polemical

    >Kerlikowske turned old school and proclaimed that drug legalization was not in the administration’s “vocabulary.”

    Of course Walters fails to inform the reading audience that Kerlikowske has abandoned Walters’ overblown rhetoric by dropping the term ‘war on drugs’ from the fed’s vocabulary.

    Attorney General Eric Holder announced that federal enforcement regarding “medical marijuana” would be dialed back, which caused the number of storefront marijuana shops in Los Angeles to skyrocket.

    Is this true? Or, is it more accurate to admit that the massive increase in the retail outlets for cannabis for medical purposes happened under the Bush/Walters tenure, specifically between 2001-2008? Even with the executive branch winning two US Supreme Court decisions against medical cannabis in 2001 and 2005, Bush and Walters (along with fellow Republican Gov. Arnold Schwarzenegger) utterly failed to stop the massive proliferation and increased popularity of retail cannabis dispensaries in states like California and Colorado.

    It was during the Carter administration that the drug problem exploded, leading to the worst destruction from substance abuse in living memory and the enduring root of the smaller problem still with us today.

    Is this historically accurate or another pathetic partisan attack? Were there not massive increases in the use of heroin (under Nixon), cocaine (under Reagan), crack (under Bush 1.0), ecstacy (under Clinton) and meth (under Bush 2.0 and Walters)?

    He could say that illegal drugs make people sick, and his generation did not understand this and paid a horrible price for its ignorance. Now we know better, and we should act like it. If he wanted to show real courage, he could say we know that marijuana makes people sick and that marijuana is the illegal drug causing the greatest dependency and addiction by far.

    Apparently Walters looks to Obama to be as dishonest as he was in misleading and lying to the public and Congress about cannabis. Walters’ absurd and unscientific claims that cannabis ‘makes people sick’ and that cannabis ‘causes the greatest dependency and addiction by far’ in a country that sells and taxes alcohol, tobacco and pharmaceuticals demonstrates how out-of-touch this man really is and how manipulative Walters tries to be with the distracted ignorance of the general public (and elected policy makers).

    He could even say it is time to stop several decades of lying to ourselves about marijuana and teaching that lie to our children.

    Talk about self-delusional! Who exactly has been lying for decades about cannabis? Was it not Walters who wasted taxpayer dollars on rank propaganda like ‘Stoners in the Mist‘? Is Walters to have his reading audience believe that government (federal and state executive branches; Congress and state legislatures; the DEA, ONDCP, NIDA, FBI, NIH, etc…) has been lying for decades to the general public in favor of cannabis, and now, Obama has a chance to retard decades of pro-cannabis government propaganda? Does this make any sense to sane people?

    But the president and all his key officials—Eric Holder, Secretary of Health and Human Services Kathleen Sebelius, Commissioner of the Food and Drug Administration Margaret Hamburg, and even Gil Kerlikowske—are playing dumb as “medical marijuana” is brought to Washington, D.C. The agencies of the federal government know what a dangerous fraud this has been in California and particularly in its large cities—Los Angeles, Oakland, and San Francisco.

    Once again, resistant to democracy and the will of the voters, Walters is vexed by the fact that voters–not politically-appointed technocrats like him–are determining their fates and public policies, and  childishly bemoaning  current federal officials for not acting in the same reckless, elitist and anti-democratic manner that Walters chose to look down his nose at the public. Obama and Kerlikowske will be as successful as Bush and Walters were at thwarting the public’s will for long overdue cannabis law reforms, which is to say, not at all.

    It is beyond question that “medical marijuana” fosters rapid rises in abuse, addiction, and crime. The Post has reported this in detail. Does the capital of the United States need a bigger drug problem? Are all these Obama administration officials really too busy to make the obvious argument that “medical marijuana” is a stupid and dangerous fraud?

    I think Walters meant to write ‘It is beyond question that prohibition laws fosters rapid rises in abuse, addiction, and crime.’

    Walter blissfully cites the Washington Post as some kind of paragon of clarity against medical cannabis, when in fact the Washington Post editorial board and its columnists over the years, like most of the country, has come to embrace medical cannabis research and law reform.

    Irony as rich as a Sara Lee poundcake

    In what really is little more than a nakedly partisan, Soros-paranoid attempt by Walters to chide Obama (and by extension the entire presidential field of Democrats in 2008 as all of them supported medical access to cannabis; contrastingly, Republican candidates other than Ron Paul did not) for 1) the audacity of agreeing with approximately 80% of the US public on the question of allowing physicians to recommend cannabis to sick, dying and sense-threatened medical patients, and 2) more importantly, for upholding a campaign promise to back the federal government off of state autonomy on the issue of medical cannabis.

    med_mj.2010.poster

    Obama, a real politician, can’t ignore 14 states (with 90 million citizens) who’ve provided legal protections for patients who use cannabis, whereas Walters, near a life-long political appointee who couldn’t get elected local dog catcher, and his duplicitous boss, for eight years, embraced a strange form of anti-democratic elitism as their way to ‘solve’ the failure of cannabis prohibition (President George W. Bush claimed as both governor of Texas and presidential candidate in 2000 that he, along with the rest of the GOP, strongly support states’ rights against a highly centralized, all-controlling federal government in big bad ol’ Washington, DC, but when the editorial board of the Portland Press Herald effectively asked candidate Bush ‘you claim you support states’ rights against encroaching federal supremacy, here in Maine voters elected to pass medical cannabis laws that run counter to federal laws. If elected president, what are you going to do regarding the increasing number of states that are rejecting federal anti-cannabis laws in favor of medicinal access for qualified patients?’ Bush’s reported reply: If elected president I’ll strongly encourage states’ rights, but will rigorously enforce existing federal laws.).

    Walter’s obscene boast in his bio at Hudson of reducing teen drug use 25% during his tenure is hard to comprehend and belies any credibility to speak publicly on the topic of cannabis prohibition, as he well knows that government drug surveys do not accurately measure drug use. Is it not ironic that when Walters is in government the monumentally unachievable is claimed, but when out of government, he is hypercritical of those in government for taking scientifically sound and politically popular decisions?

    Mirabile dictu

    Rather than salivate and snipe in such a partisan way at Democrats who’re responding to the will of the American people on medical cannabis, I suggest Walters and his fellow neo-cons at Hudson (like Lewis Libby, Robert Bork and Norman Podhoretz) should instead pay much more attention closer to home as his fellow conservatives are increasingly abandoning Nixon and Reagan-era policies intended to deter drug use.

    How much must it sting for Walters to read about the recent reversal in thinking and advocacy of John Dilulio about drug policy reform? It can’t feel too good when a respected co-author abandons and rejects, for all good and obvious reasons, long-claimed theories and advocacy, and Walters (and Bennett) is still clinging to bogus data, racist criminal justice enforcement and cultural elitism as their justification to continue a self-evidently failed public policy like cannabis prohibition.

    The former director of President George W. Bush’s White House Office of Faith-Based and Community Initiatives, and the co-author with former Drug Czars Bill Bennett and John Walters of the book “Body Count: Moral Poverty…And How to Win America’s War Against Crime and Drugs” has just come out in favor of medical marijuana and serious consideration of marijuana decriminalization.

    [In a] 1993 book review for The New Republic, he implied that [drug users] were getting off too lightly. “It is not unreasonable to argue,” he wrote, “that the problem with the ‘get-tough’ approach of the last twenty-five years is that it hasn’t actually been followed. Despite mandatory sentencing laws, most drug offenders and other felons continue to spend only a fraction of their sentences behind bars.”

    In a recent article in Democracy his prescription for reducing crime addresses marijuana thusly…

    “… legalize marijuana for medically prescribed uses, and seriously consider decriminalizing it altogether. Last year there were more than 800,000 marijuana-related arrests. The impact of these arrests on crime rates was likely close to zero. There is almost no scientific evidence showing that pot is more harmful to its users’ health, more of a “gateway drug,” or more crime-causing in its effects than alcohol or other legal narcotic or mind-altering substances. Our post-2000 legal drug culture has untold millions of Americans, from the very young to the very old, consuming drugs in unprecedented and untested combinations and quantities. Prime-time commercial television is now a virtual medicine cabinet (”just ask your doctor if this drug is right for you”). Big pharmaceutical companies function as all-purpose drug pushers. And yet we expend scarce federal, state, and local law enforcement resources waging “war” against pot users. That is insane.”

    One has to wonder what Walters thinks when he witnesses dyed-in-the-blue conservatives like Wall Street Journal columnist Mary O’Grady speak out this week against the obvious, tax-draining, border-destabilizing and ineffective public policy of prohibiting so-called recreational drugs like cannabis?

    Revolving government door-types like Walters—who was paid over $1 million by taxpayers to, in the minds of many critics, twist scientific data and oppose democracy in his tenure as ‘drug czar’—should try to minimize their hypocrisy less they may reduce their value next time the political winds change and they, again, get to be a highly paid political apparatchik.

  • by Allen St. Pierre, NORML Executive Director January 19, 2010

    You can’t get more mainstream in the media than The New York Times and Wall Street Journal, who both highlight the growing medical acceptance of medical cannabis and the uber-political conditions placed on medical researchers who want to conduct rigorous scientific studies on cannabis’ medical efficacy and safety.

    RESEARCHERS FIND STUDY OF MEDICAL MARIJUANA DISCOURAGED
    by Gardiner Harris
    January 19, 2010
    ——-
    Despite the Obama administration’s tacit support of more liberal state medical marijuana laws, the federal government still discourages research into the medicinal uses of smoked marijuana.  That may be one reason that — even though some patients swear by it – — there is no good scientific evidence that legalizing marijuana’s use provides any benefits over current therapies.

    Lyle E.  Craker, a professor of plant sciences at the University of Massachusetts, has been trying to get permission from federal authorities for nearly nine years to grow a supply of the plant that he could study and provide to researchers for clinical trials.

    But the Drug Enforcement Administration — more concerned about abuse than potential benefits — has refused, even after the agency’s own administrative law judge ruled in 2007 that Dr.  Craker’s application should be approved, and even after Attorney General Eric H.  Holder Jr.  in March ended the Bush administration’s policy of raiding dispensers of medical marijuana that comply with state laws.

    “All I want to be able to do is grow it so that it can be tested,” Dr.  Craker said in comments echoed by other researchers.

    Marijuana is the only major drug for which the federal government controls the only legal research supply and for which the government requires a special scientific review.

    “The more it becomes clear to people that the federal government is blocking these studies, the more people are willing to defect by using politics instead of science to legalize medicinal uses at the state level,” said Rick Doblin, executive director of a nonprofit group dedicated to researching psychedelics for medical uses.

    On Monday, his last full day in office, Gov.  Jon S.  Corzine of New Jersey signed a measure passed by the Legislature last week that made the state the 14th in the nation to legalize the use of marijuana to help with chronic illnesses.

    The measure was pushed by a loose coalition of patients suffering from chronic illnesses like Lou Gehrig’s disease and multiple sclerosis who said marijuana eased their symptoms.

    Studies have shown convincingly that marijuana can relieve nausea and improve appetite among cancer patients undergoing chemotherapy.  Studies also prove that marijuana can alleviate the aching and numbness that patients with H.I.V.  and AIDS suffer.

    There are strong hints that marijuana may ameliorate some of the neurological problems associated with such degenerative diseases as multiple sclerosis, said Dr.  Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California, San Diego.

    But there is no good evidence that legalizing the smoking of marijuana is needed to provide these effects.  The Food and Drug Administration in 1985 approved Marinol, a prescription pill of marijuana’s active ingredient, T.H.C.  Although a few small-scale studies done decades ago suggest that smoked marijuana may prove effective when Marinol does not, no conclusive research has confirmed this finding.

    And Marinol is no panacea.  There are at least three medicines that in most patients provide better relief from nausea and vomiting than Marinol, studies show.

    Buddy Coolen, 31, of Warwick, R.I., said he tried or continued to use some of those medicines.  “Smoking for me is as good as any medicine I have,” he said.

    Eight years ago, Mr.  Coolen contracted gastroparesis and cyclic vomiting syndrome.  He lost 50 pounds and, despite being 5 foot 11, weighed 120 pounds.

    His doctors gave him myriad anti-emetics, many of which he still takes.  They also prescribed Marinol, but it did not work for him, Mr.  Coolen said.

    “My stepdad is old school and was really against marijuana, but then he saw what it did for me and totally changed his way of thinking,” Mr.  Coolen said.

    Some doctors and law enforcement officials say such anecdotes should not drive public policy.  Dr.  Eric Braverman, medical director of a multispecialty clinic in Manhattan, said legalizing marijuana was unnecessary and dangerous since Marinol provided the medicinal effects of the plant.  “Our society will deteriorate,” he said.

    Patients who call Dr.  Braverman’s clinic are, when put on hold, told that the clinic may prescribe supplements and other alternative treatments that have even less scientific justification than marijuana.  Dr.  Braverman said such alternatives rendered marijuana unnecessary, but his embrace of alternatives is a reminder that medicine has long been driven by more than science.

    About 20 percent of drug prescriptions are written for uses that are not approved by federal drug regulators; about half of the nation’s adults regularly take supplements; herbal and homeopathic remedies are popular.

    The nation’s growing embrace of medical marijuana has stemmed from these alternative traditions.

    The University of Mississippi has the nation’s only federally approved marijuana plantation.  If they wish to investigate marijuana, researchers must apply to the National Institute on Drug Abuse to use the Mississippi marijuana and must get approvals from a special Public Health Service panel, the Drug Enforcement Administration and the Food and Drug Administration.

    But federal officials have repeatedly failed to act on marijuana research requests in a timely manner or have denied them, according to a 2007 ruling by an administrative law judge at the Drug Enforcement Administration.  While refusing to approve a second marijuana producer, the government allowed the University of Mississippi to supply Mallinckrodt, a drug maker, with enough marijuana to eventually produce a generic version of Marinol.

    “As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use,” said Shirley Simson, a spokeswoman for the drug abuse institute, known as NIDA.  “We generally do not fund research focused on the potential beneficial medical effects of marijuana.”

    The Drug Enforcement Administration said it was just following NIDA’s lead.  “D.E.A.  has never denied a research registration for marijuana and/or THC if NIDA approved the protocols for that individual entity,” a supervisory special agent, Gary Boggs, said by e-mail.

    Researchers investigating LSD, Ecstasy and other illegal drugs can use any of a number of suppliers licensed by the Drug Enforcement Administration, Dr.  Doblin said.  And if a researcher wants to use a variety of marijuana that the University of Mississippi does not grow – — and there are many with differing medicinal properties — they are out of luck, Dr.  Doblin said.

    Law enforcement tends to emphasize the abuse potential of medicines without regard to their positive effects.  Bureaucratic battles between the D.E.A.  and the F.D.A.  over the availability of narcotics – — highly effective but addictive medicines — have gone on for decades.

    So medical marijuana may never have good science underlying its use.  But for patients in desperate need, the ethics of providing access to the drug are clear, said Dr.  Richard Payne, a professor of medicine and divinity and director of the Institute for Care on the End of Life at Duke Divinity School.

    “It’s not a great drug,” he said, “but what’s the harm?”

    * * * * * * * * * * *

    IS MARIJUANA A MEDICINE?
    by Anna Wilde Mathews, (Source:Wall Street Journal)
    19 Jan 2010
    Share This Article

    United States
    ——-
    Charlene DeGidio never smoked marijuana in the 1960s, or afterward.  But a year ago, after medications failed to relieve the pain in her legs and feet, a doctor suggested that the Adna, Wash., retiree try the drug.

    Ms.  DeGidio, 69 years old, bought candy with marijuana mixed in.  It worked in easing her neuropathic pain, for which doctors haven’t been able to pinpoint a cause, she says.  Now, Ms.  DeGidio, who had previously tried without success other drugs including Neurontin and lidocaine patches, nibbles marijuana-laced peppermint bars before sleep, and keeps a bag in her refrigerator that she’s warned her grandchildren to avoid.

    “It’s not like you’re out smoking pot for enjoyment or to get high,” says the former social worker, who won’t take the drug during the day because she doesn’t want to feel disoriented.  “It’s a medicine.”

    For many patients like Ms.  DeGidio, it’s getting easier to access marijuana for medical use.  The U.S.  Department of Justice has said it will not generally prosecute ill people under doctors’ care whose use of the drug complies with state rules.  New Jersey will become the 14th state to allow therapeutic use of marijuana, and the number is likely to grow.  Illinois and New York, among others, are considering new laws.

    As the legal landscape for patients clears somewhat, the medical one remains confusing, largely because of limited scientific studies.  A recent American Medical Association review found fewer than 20 randomized, controlled clinical trials of smoked marijuana for all possible uses.  These involved around 300 people in all–well short of the evidence typically required for a pharmaceutical to be marketed in the U.S.

    Doctors say the studies that have been done suggest marijuana can benefit patients in the areas of managing neuropathic pain, which is caused by certain types of nerve injury, and in bolstering appetite and treating nausea, for instance in cancer patients undergoing chemotherapy.  “The evidence is mounting” for those uses, says Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California, San Diego.

    But in a range of other conditions for which marijuana has been considered, such as epilepsy and immune diseases like lupus, there’s scant and inconclusive research to show the drug’s effectiveness.  Marijuana also has been tied to side effects including a racing heart and short-term memory loss and, in at least a few cases, anxiety and psychotic experiences such as hallucinations.  The Food and Drug Administration doesn’t regulate marijuana, so the quality and potency of the product available in medical-marijuana dispensaries can vary.

    Though states have been legalizing medical use of marijuana since 1996, when California passed a ballot initiative, the idea remains controversial.  Opponents say such laws can open a door to wider cultivation and use of the drug by people without serious medical conditions.  That concern is heightened, they say, when broadly written statutes, such as California’s, allow wide leeway for doctors to decide when to write marijuana recommendations.

    But advocates of medical-marijuana laws say certain seriously ill patients can benefit from the drug and should be able to access it with a doctor’s permission.  They argue that some patients may get better results from marijuana than from available prescription drugs.

    Glenn Osaki, 51, a technology consultant from Pleasanton, Calif., says he smokes marijuana to counter nausea and pain.  Diagnosed in 2005 with advanced colon cancer, he has had his entire colon removed, creating digestive problems, and suffers neuropathic pain in his hands and feet from a chemotherapy drug.  He says smoking marijuana was more effective and faster than prescription drugs he tried, including one that is a synthetic version of marijuana’s most active ingredient, known as THC.

    The relatively limited research supporting medical marijuana poses practical challenges for doctors and patients who want to consider it as a therapeutic option.  It’s often unclear when, or whether, it might work better than traditional drugs for particular people.  Unlike prescription drugs it comes with no established dosing regimen.

    “I don’t know what to recommend to patients about what to use, how much to use, where to get it,” says Scott Fishman, chief of pain medicine at the University of California, Davis medical school, who says he rarely writes marijuana recommendations, typically only at a patient’s request.

    Researchers say it’s difficult to get funding and federal approval for marijuana research.  In November, the AMA urged the federal government to review marijuana’s position in the most-restricted category of drugs, so it could be studied more easily.

    Gregory T.  Carter, a University of Washington professor of rehabilitation medicine, says he’s developed his own procedures for recommending marijuana, which he does for some patients with serious neuromuscular conditions such as amyotrophic lateral sclerosis, or Lou Gehrig’s disease, to treat pain and other symptoms.  He typically urges those who haven’t tried it before to start with a few puffs using a vaporizer, which heats the marijuana to release its active chemicals, then wait 10 minutes.  He warns them to have family nearby and to avoid driving, and he checks back with them after a few days.  Many are “surprised at how mild” the drug’s psychotropic effects are, he says.

    States’ rules on growing and dispensing medical marijuana vary.  Some states license specialized dispensaries.  These can range from small storefronts to bigger operations that feel more like pharmacies.  Typically, they have security procedures to limit walk-in visitors.

    At least a few dispensaries say they inspect their suppliers and use labs to check the potency of their product, though states don’t generally require such measures.  “It’s difficult to understand how we can call it medicine if we don’t know what’s in it,” says Stephen DeAngelo, executive director of the Harborside Health Center, a medical-marijuana dispensary in Oakland, Calif.

    Some of the strongest research results support the idea of using marijuana to relieve neuropathic pain.  For example, a trial of 50 AIDS patients published in the journal Neurology in 2007 found that 52% of those who smoked marijuana reported a 30% or greater reduction in pain.  Just 24% of those who got placebo cigarettes reported the same lessening of pain.

    Marijuana has also been shown to affect nausea and appetite.  The AMA review said three controlled studies with 43 total participants showed a “modest” anti-nausea effect of smoked marijuana in cancer patients undergoing chemotherapy.  Studies of HIV-positive patients have suggested that smoked marijuana can improve appetite and trigger weight gain.

    Donald Abrams, a doctor and professor at the University of California, San Francisco who has studied marijuana, says he recommends it to some cancer patients, including those who haven’t found standard anti-nausea drugs effective and some with loss of appetite.

    Side effects can be a problem for some people.  Thea Sagen, 62, an advanced neuroendocrine cancer patient in Seaside, Calif., says she expected something like a pharmacy when she went to a marijuana dispensary mentioned by her oncologist.  She says she was disappointed to find that the staffers couldn’t say which of the products, with names like Pot ‘o Gold and Blockbuster, might boost her flagging appetite or soothe her anxiety.  “They said, ‘it’s trial and error,’ “she says.  “I was in there flying blind, looking at all this stuff.”

    Ms.  Sagen says she bought several items and tried one-eighth teaspoon of marijuana-infused honey.  After a few hours, she was hallucinating , too dizzy and confused to dress herself for a doctor’s appointment.  Then came vomiting far worse than her stomach upset before she took the drug.  When she reported the side effects to her oncologist’s nurse and her primary-care physician, she got no guidance.  She doesn’t take the drug now.  But with advice from a nutritionist, her appetite and food intake have improved, she says.

    Other marijuana users may experience the well-known reduction in ability to concentrate.  At least a few users suffer troubling short-term psychiatric side effects, which can include anxiety and panic.  More controversially, an analysis published in the journal Lancet in 2007 tied marijuana use to a higher rate of psychotic conditions such as schizophrenia.  But the analysis noted that such a link doesn’t necessarily show marijuana is a cause of the conditions.

    Long-term marijuana use can lead to physical dependence, though it is not as addictive as nicotine or alcohol, says Margaret Haney, a professor at Columbia University’s medical school.  Smoked marijuana may also risk lung irritation, but a large 2006 study, published in Cancer Epidemiology, Biomarkers & Prevention, found no tie to lung cancer.